MNA
NVO

Manning & Napier Advisors’s Novo Nordisk NVO Stock Holding History

Manning & Napier Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.54K Sell
156
-173,011
-100% -$7.43M ﹤0.01% 540
2026
Q1 		$6.36M Buy
173,167
+6,235
+4% +$295K 0.09% 135
2025
Q4 		$8.55M Sell
166,932
-15,269
-8% -$781K 0.11% 104
2025
Q3 		$10.1M Sell
182,201
-21,973
-11% -$1.29M 0.13% 89
2025
Q2 		$14.1M Buy
+204,174
New +$13.9M 0.17% 94

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Manning & Napier Advisors's NVO Position: Q2 2026 in Review

Manning & Napier Advisors reduced its Novo Nordisk (NVO) stake by 100% in Q2 2026, selling an estimated $7.43M and leaving 156 shares worth $7.54K. The position accounts for ﹤0.01% of the portfolio, ranked #540.

Manning & Napier Advisors first reported a position in NVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $14.1M in Q2 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Manning & Napier Advisors held 156 shares of Novo Nordisk worth $7.54K as of Q2 2026.
  • Manning & Napier Advisors sold 173,011 Novo Nordisk shares in Q2 2026, an estimated $7.43M.
  • Novo Nordisk made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q2 2026, its #540 holding.
  • Manning & Napier Advisors first reported a position in Novo Nordisk in Q2 2025 and has held it in 5 quarters since.
  • Manning & Napier Advisors's Novo Nordisk position peaked at $14.1M in Q2 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.